ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01238952
Recruitment Status : Completed
First Posted : November 11, 2010
Last Update Posted : November 13, 2014
Sponsor:
Information provided by (Responsible Party):
Nippon Kayaku Co.,Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2010
  Actual Study Completion Date : March 2013